|
|
Volumn 22, Issue 8 SUPPL., 1999, Pages
|
|
Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: Unstable angina/non-ST-segment elevation myocardial infarction
|
|
Author keywords
Coronary intervention; Glycoprotein IIb IIIa; Pathway; Unstable angina
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
LAMIFIBAN;
PLACEBO;
TIROFIBAN;
FIBRINOLYTIC AGENT;
RETEPLASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
CLINICAL PATHWAY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY BYPASS GRAFT;
CORONARY STENT;
COST EFFECTIVENESS ANALYSIS;
HEART INFARCTION;
HUMAN;
MORTALITY;
ST SEGMENT ELEVATION;
THROMBOCYTE AGGREGATION INHIBITION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNSTABLE ANGINA PECTORIS;
ACUTE HEART INFARCTION;
BLEEDING;
BRAIN HEMORRHAGE;
DOSE RESPONSE;
DRUG SAFETY;
FIBRINOLYTIC THERAPY;
ANGINA, UNSTABLE;
ASPIRIN;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
HUMANS;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET COUNT;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
SURVIVAL ANALYSIS;
THROMBOLYTIC THERAPY;
|
|
EID: 0032811050
PISSN: 01609289
EISSN: None
Source Type: Journal
DOI: 10.1002/clc.4960221606 Document Type: Conference Paper |
|
Times cited : (17)
|
|
References (31)
|
